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A B S T R A C T
The biophysical properties and biological functions of membranes are highly dependent on lipid composition.
Supplementing cellular membranes with very long chain fatty acids (vlcFAs) is notoriously difficult given the
extreme insolubility of vlcFAs in aqueous solution. Herein, we report a solvent-free, photochemical approach to
enrich target membranes with vlcFA. To prevent aggregation of vlcFA, we created light-sensitive micelles
composed exclusively of poly-ethylene-glycol-nervonic acid amphiphiles (NA-PEG), which spontaneously dis-
assemble in the presence of lipid bilayers. Once embedded within a membrane, UV light is used to cleave off
PEG, leaving free nervonic acid (NA, i.e. FA24:1) in the target membrane. When applied to living cells, free NA
was processed by the cell to generate various species of membrane and other lipids with incorporated vlcFAs. In
this way, we were able to alter the membrane lipid composition of cellular membranes and modulate the en-
zymatic activity of γ-secretase, an intramembrane protease whose dysfunction has been implicated in the onset
and progression of Alzheimer's disease.
1. Introduction
Phospholipid bilayers, as the main constituent of cellular mem-
branes, maintain the structural integrity of cells and are critically im-
portant to numerous cellular processes. The activity and function of
membrane proteins is dependent on the local properties of the lipid
bilayer in which they are embedded [1]. As such, the transmembrane
domains (TMD) of many membrane proteins have evolved to prefer a
specific lipid bilayer environment [2]. Slight changes of bilayer thick-
ness, fluidity, curvature, and/or lipid headgroup chemistry can there-
fore lead to destabilization of membrane protein structure and affect
function and activity [2–4].
Very long-chain fatty acids (vlcFAs) with a chain-length of ≥22
carbon atoms are important precursors of inflammation-resolving lipid
mediators, and play a vital role in cellular functions including sper-
matogenesis, skin barrier formation and myelin maintenance [5]. Sev-
eral disorders in the synthesis of vlcFAs (e.g. elongation of stearic acid
to saturated or mono-unsaturated vlcFAs) as well as defects in vlcFA
metabolism can lead to severe diseases, such as Stargardt disease and
adrenoleukodystrophy [5]. Free, unesterified vlcFA can rapidly diffuse
across lipid bilayers and redistribute among various cellular compart-
ments [6,7]. When incorporated within endogenous membrane lipids
(e.g. sphingo- and glycero-phospholipids), vlcFAs are key modulators of
membrane fluidity and thickness, and facilitate the formation of lipid
rafts/domains within cell membranes [8]. A change in vlcFA content of
a cell membrane may create a hydrophobic mismatch between the li-
pids and hydrophobic TMDs of embedded membrane proteins [9].
Accordingly, to minimize unfavorable interactions (e.g. exposure of
hydrophobic amino acids to water), a change in membrane hydro-
phobicity may force a membrane protein to alter its state to a more
energetically favorable orientation, for instance, by tilting and bending
its TMDs in the new membrane landscape. This, in turn, can alter the
ability of the protein to carry out its function and, in extreme cases, may
lead to a complete loss of function [4]. Thus, the activity of ion chan-
nels, transporters and membrane-associated enzymes have all been
shown sensitive to changes in lipid membrane composition [10–13].
As acyl-chain remodelling pathways readily incorporate exogenous
fatty acids into cellular membrane lipids, delivery of vlcFAs to cells is
an attractive option to artificially modulate the physicochemical
properties of cell membranes and, thereby, the activity of membrane
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proteins [14,15]. The delivery of vlcFAs to model membranes or cells is,
however, complicated by the extreme insolubility of these reagents in
aqueous media. This is particularly problematic in the case of vlcFAs
with a low degree of unsaturation, e.g. nervonic acid (NA, i.e. FA 24:1).
When injected from a solvent (e.g. ethanol or DMSO), these species
immediately form insoluble aggregates upon dilution in water. Our
motivation for this study was, therefore, to find ways of solubilizing
vlcFAs to enable efficient incorporation into target membranes. Once
embedded in the plasma membrane, we hypothesized that delivered
vlcFAs would be taken up into cellular compartments, enter membrane
remodelling pathways [15] and be incorporated into cellular phos-
pholipids. This would, in turn, create larger hydrophobic domains
within the lipid bilayer of the cellular membrane and potentially
modulate membrane protein activity [3,4].
Herein, we describe a solvent-free method to enrich target mem-
branes with vlcFAs in a photo-inducible manner. To achieve this, NA
was chemically conjugated to poly-ethylene-glycol (PEG) via a photo-
cleavable (o-nitrobenzyl) linker (NA-PEG, Fig. 1) to form vlcFA am-
phiphiles that self-assemble to close-packed micelles in aqueous media.
These micelles spontaneously disassemble in the presence of a lipid
bilayer to embed NA-PEG within the target membrane (Fig. 1). Once
embedded, photolysis of PEG releases free (i.e. unesterified) NA into the
membrane. When we applied our methods to cells, lipidomic analysis
demonstrated that free NA was processed by the cell, resulting in ele-
vated levels of vlcFA-containing phospholipids within the cellular
membranes. Finally, by altering the lipid composition of cellular
membranes in this way, we were able to modulate the enzymatic ac-
tivity of γ-secretase leading to a reduction of the relative amount of
toxic amyloid-β42 (Aβ42) peptides secreted by treated cells. γ-Secretase
dysfunction, and the associated increase in the secretion of Aβ42 re-
lative to Aβ40 peptides, is widely believed to contribute to the onset and
progression of Alzheimer's disease [16,17].
2. Results & discussion
The synthesis and chemical characterization of photolabile, ner-
vonic acid-o-nitrobenzyl-PEG2000, NA-PEG, is described in the
Experimental procedures (Scheme S1, Fig. S1 – for 1HNMR spectra of
NA-PEG, Fig. S2 – for MALDI MS of NA-PEG). Upon UV light irradiation
in PBS, complete photolysis was achieved within 30 min (Fig. 2a,b).
The appearance of a clear isosbestic point at 320 nm in the UV–Vis
absorption spectra indicated clean photoconversion of NA-PEG to its
photoproducts. High performance liquid chromatography-evaporative
light scattering (HPLC-ELSD) analysis confirmed the expected release of
free NA (Fig. 2c). Self-assembly of NA-PEG in aqueous media resulted in
close-packed micelles of approximately 15 nm in size (polydispersity
index, PDI < 0.2), as determined by dynamic light scattering (DLS,
Fig. S4). Micelles, visualized by electron microscopy (Fig. 2d), appeared
slightly larger (approx. 25 nm), most likely due to a drying effect during
TEM sample preparation. The critical micelle concentration (CMC) of
NA-PEG was 2.9 μM (Fig. S3) and particles were stable up to at least
1 mM NA-PEG (Fig. S4).
Fig. 1. Delivery, UV-light cleavage of PEG and processing of nervonic acid by target cells. (Top) Chemical structure of light sensitive nervonic acid-PEG conjugate
(NA-PEG). (Middle) Self-assembly of NA-PEG to form close packed micelles in aqueous media. (Bottom) Spontaneous disassembly and insertion of NA-PEG micelles in
the presence of (cellular) lipid bilayers, followed by light triggered release of free NA and proposed membrane lipid remodelling.
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Next, the incorporation of NA-PEG into model POPC (1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine) membranes was assessed (Fig. 3a).
For this, an aliquot of NA-PEG micelles (1 mM NA-PEG in PBS) was
mixed with preformed POPC liposomes (i.e. large unilamellar vesicles,
90 nm, Fig. 3b) at a 1:10 molar ratio (final concentration: 100 μM NA-
PEG and 1 mM POPC). Successful incorporation of NA-PEG into the
POPC liposome membrane was, in part, confirmed by a small increase
in the hydrodynamic diameter (Dh) of the liposomes (as measured by
DLS), prior to light activation (Fig. 3b). We attribute this to the addi-
tional PEG corona presented from the outer leaflet of the POPC lipo-
some membrane. As expected, upon UV light irradiation and photolysis
of the PEG corona, the Dh returned to the original size of the parent
POPC liposome. Likewise, a significant decrease in measured zeta po-
tential, from −8 mV to −25 mV, was observed following UV radiation
of NA-PEG loaded POPC liposomes (Fig. 3c). This can be attributed to
the negative charge of the liberated carboxylate headgroup of free NA.
Together, these observations confirm successful incorporation of NA
into model lipid bilayers by our procedure. In contrast, addition of NA
(via ethanol injection) to POPC liposomes resulted in no substantial
change to the liposome surface charge (Fig. 3c), highlighting the dif-
ficulties of incorporating highly insoluble vlcFAs into lipid membranes
by conventional methods [6].
To verify analogous incorporation of NA-PEG into biological
membranes, we prepared micelles of NA-PEG containing 1 mol%
fluorescently-labeled nervonic acid (NA-Fluo, see Experimental proce-
dures for synthesis and characterization, Fig. S5 for analytical HPLC
trace of NA-Fluo). When mixed micelles of NA-PEG and NA-Fluo were
incubated with HeLa cells, fluorescence of the cells was immediately
observed (Fig. S6). This indicated NA-Fluo spontaneously incorporated
into cellular membranes through a process of disassembly of mixed
micelles and subsequent transfer of both NA-PEG and NA-Fluo to cel-
lular membranes.
Next, we investigated whether cells could process free NA, following
photolysis of NA-PEG delivered to the cell membrane, to generate ele-
vated levels of specific phospholipids with incorporated vlcFAs.
Following incubation of NA-PEG (100 μM) and subsequent UV-light
cleavage of PEG, cells were incubated to allow for processing and in-
corporation of the delivered NA into endogenous phospholipids. For
this, HEK293 (APPsw) cells, overexpressing Aβ precursor protein
(APP), were chosen as these cells were also used in subsequent ex-
periments investigating the impact of changes in membrane lipids on
APP processing by γ-secretase (see below). To monitor potential cyto-
toxicity of NA-PEG + UV treatment, we first looked at acute (3 h after
irradiation) vs long term effects (72 h after irradiation) of UV irradia-
tion of cells. Here, we found that 3 h after UV irradiation, cells dis-
played reduced metabolic activity, as detected by the MTS assay (Fig.
Fig. 2. Photolysis of NA-PEG and biophysical characterization of NA-PEG micelles. (a) Time evolution of the UV–Vis spectra of a solution of NA-PEG during
photolysis (365 nm, 3–5 mW/cm2); (b) Time evolution of the UV absorbance at 350 nm during photolysis. (c) HPLC-ELSD analysis of NA-PEG before (red, single
peak) and after UV irradiation (blue; left peak: PEG, right peak NA). HPLC-ELSD analysis of free NA (black, single peak) was used to confirm photolysis of NA-PEG to
free NA. (d) TEM images (uranyl acetate stain) of micelles of NA-PEG (500 μM, 1.31 mg ml−1). Inset: Size distribution of NA-PEG micelles (n = 90 measured
particles), observed by TEM. The average size (diameter) of NA-PEG micelles, as observed by dry TEM is approx. 25 nm.
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S7a). Cell viability was dependent on irradiation time (i.e. 10, 20 or
30 min) but also the presence of NA-PEG in the cell membrane. This
acute toxicity is most likely caused by a combination of the UV light,
NA-PEG in the plasma membrane and/or UV triggered release of large
amounts of NA within the cell membrane. However, 72 h after NA-PEG
addition, the relative viability of the cells was ~75%, as compared to
the PBS control, irrespective of initial 10 min UV irradiation (Fig. S7b).
This suggests, after 72 h incubation, cells can recover from the initial
stress, continue to grow and thereby process large amount of released
NA. Accordingly, following photolysis of NA-PEG delivered to the cell
membrane and after 72 h incubation, cells were pelleted and cellular
lipids extracted and analyzed by thin layer chromatography (TLC). As
shown in Fig. S8, TLC demonstrated that only in the case of treated and
irradiated cells were substantial amounts of NA incorporated within
endogenous PC lipids – the most common class of endogenous phos-
pholipids in cells [18].
To further characterize the specific phospholipid composition of
treated cells, we next identified and quantified 265 individual lipid
species through LC-MS/MS lipidomic analysis (Fig. 4, for raw data of all
lipid species - see Supplementary Table S1). For comparison, we in-
cluded NA delivered to cells via BSA (i.e. BSA-NA complex), a com-
monly used method for delivering FA to cells [19]. The lipidomic
analysis revealed a large increase of free NA, from very low levels
(0.38% in the control) up to 9.1% of the total cellular FA upon treat-
ment with NA-PEG + UV (Fig. 4a, Supplementary Table S1). This was
comparable to delivery of NA using BSA (13.6% of cellular FA) (Fig. 4a,
Supplementary Table S1). Furthermore, released free NA was processed
and incorporated extensively into membrane lipids. Thus, after treat-
ment with NA-PEG+ UV, 8.23% of the membrane lipids contained acyl
chains with ≥22C-atoms (i.e. contained at least one esterified vlcFA),
representing an almost 5.6% increase compared to control (PBS + UV
treated) cells (Fig. 4b). This was a larger increase compared to NA
delivered via BSA (4.2% increase). For some individual lipid species,
the treatment caused a large relative change, for example, the amount
of PC 18:1–24:1 was increased 106-fold upon NA-PEG + UV treatment
compared to the PBS control, whereas common phospholipid species
with long chain FA were reduced (Fig. 4c,d; Supplementary Table S1).
Similar effects were achieved for the NA delivery via BSA. The largest
shifts in overall acyl chain composition were observed for sphingo-
myelin (SM) lipids, where the amount of SM d18:1/24:1 increased from
18%, under normal conditions, to 47% of the total observed SM, at the
expense of SM d18:1/24:0 and SM d18:1/16:0. Remarkably, changes in
these specific SM lipids were much less when NA was delivered via BSA
(Fig. 4e). In all cases, changes in the lipidome, as a result of NA-PEG
treatment, were mostly acyl chain remodelling events. Thus, in each
individual lipid class, minimal changes in the relative proportion of the
major membrane lipid classes were observed (Fig. S9). However, a large
amount of free NA was incorporated into the triglyceride storage lipids
(Fig. S9, Supplementary Table S1). It was also noted that some in-
corporation of NA was observed in the presence of NA-PEG treated cells
which were not UV irradiated. This we attribute to degradation of NA-
PEG, which contains a hydrolysable ester bond, within the cell mem-
brane during the 72 h incubation period (Fig. 4a, c–e).
Finally, we investigated whether the enrichment of cellular mem-
branes with vlcFAs could modulate the function of a membrane-asso-
ciated enzyme. γ-Secretase is a protease which generates Aβ peptides by
intramembrane cleavage of the C-terminal fragment (C99) from the
amyloid precursor protein (APP) [17]. It is widely believed that the
ratio of the production and secretion of toxic Aβ42 over less toxic Aβ40
and Aβ38 species plays an important role in the onset and progression of
Alzheimer's Disease (AD) [16,21]. Interestingly, in vitro activity of γ-
secretase has been shown to be beneficially modified when the enzyme
was reconstituted in thicker model membranes, resulting in a reduced
Aβ42:Aβtotal ratio of released Aβ species [13]. To test whether en-
dogenous γ-secretase activity could be modulated in a similar way
(Fig. 5a), HEK293 (APPsw) cells, an APP mutant which has increased
production of secreted Aβ [22], were incubated with NA-PEG and
subsequently irradiated. After 72 h further incubation, the relative
amounts of secreted Aβ peptides were analyzed using a highly specific
immunoassay [23]. Here, and only in the case of cells treated with NA-
PEG and subsequently irradiated, the cleavage precision of C99 pro-
cessing was significantly altered, resulting in cells producing relatively
more Aβ38 species, relatively less Aβ42 species (Fig. 5b) and a sig-
nificantly (about 20%) reduced Aβ42:Aβtotal ratio in the levels of
Fig. 3. Incorporation and activation of NA-PEG in model lipid membranes. (a) Cartoon of the procedure. (b) Measured hydrodynamic diameter (Dh) and (c) zeta
potentials of micelles of NA-PEG and POPC liposomes. From l to r: micelles of NA-PEG, unmodified POPC liposomes, POPC liposomes after ethanol injection of NA,
and, alternatively: POPC liposomes incubated with NA-PEG (10:1 molar ratio), followed by UV light irradiation and photolytic loss of PEG.
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secreted Aβ (Fig. 5c). This change in Aβ42:Aβtotal ratio mirrored the
increased level of incorporated vlcFAs (Fig. 4b). It is, therefore, rea-
sonable to conclude that this 6% increase in membrane lipids con-
taining ≥22C acyl chains may lead to an altered local lipid environ-
ment around γ-secretase, leading to approximately 20% reduction in
the relative amount of secreted Aβ42.
3. Significance
In this work, we demonstrate an efficient, solvent-free method to
deliver vlcFAs to target membranes. By applying this method to cells,
we show that subsequent cellular processing of delivered vlcFA leads to
elevated levels of lipids with incorporated vlcFAs. Increased vlcFA
content and membrane remodelling will result in multiple changes to
the biophysical properties of the membranes, potentially affecting
thickness, surface charge, packing and fluidity. Interestingly, we could
demonstrate that the membrane remodelling following NA-PEG treat-
ment resulted in the modification of γ-secretase activity, possibly due to
local alterations of the membrane in which γ-secretase is embedded,
reducing the relative amount of Aβ42, which is thought to be a key
factor in AD pathogenesis [16,17].
Our approach has a number of potential advantages for delivering
vlcFA to cells over existing methods. Typically, FA species are injected
from a concentrated stock solution from ethanol/DMSO, or conjugated
to BSA for delivery, which can be toxic to cells [19,24]. Binding of
vlcFAs, such as NA to BSA, has been reported to be inefficient, which
means that vlcFA require high amounts of BSA for delivery [25].
Furthermore, BSA is able to sequester other lipids from cells, which is
avoided by the use of NA-PEG [19]. The lipidomics data presented in
this paper show that the effect on membrane remodelling through de-
livery of free NA via our NA-PEG + UV method is elevated compared to
using BSA as a vehicle for NA delivery to cells. In particular, for in-
corporation of NA in specific targets, such as SM d18:1/24:1, our NA-
PEG + UV method was much more effective than BSA-NA. Finally, our
new method overcomes the insolubility of extremely hydrophobic
molecules and is expected to be transferable to the delivery of any
vlcFA or other very hydrophobic lipid species to target membranes. By
nature of its UV-activated FA release, we suggest that NA-PEG could
also have special applications in live-cell microscopy experiments, for
example where the FA can be ‘uncaged’ in a spatially and temporally-
restricted manner using two photon excitation sources. These properties
make the PEG delivery of FA reported in this paper an attractive novel
approach to studying cellular processes related to disease-related al-
tered levels of vlcFA.
4. Experimental procedures
4.1. Materials and methods
4.1.1. Materials
All chemical reagents, including nervonic acid (NA), were pur-
chased from Sigma Aldrich and used without further purification.
Synthetic lipids (POPC (16:0/18:1 PC), diC22:1 (Δ9-cis) PC and diC24:1
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Fig. 4. Membrane remodelling in HEK293 (APPsw) cells following NA-PEG + UV treatment. (a) Relative percentage of different free FA species in the lipid extracts
of cells treated with PBS ± UV, NA-PEG±UV or BSA-NA. (b) Pie chart showing proportion of membrane lipids containing acyl chains< 22C-atoms and ≥22C-
atoms, analyzed from the lipid extracts of control (PBS), NA-PEG + UV and BSA-NA treated cells. (c,d) Bar graph showing the percentage of selected, individual (c)
long chain (< 22C) and (d) very long chain (≥22C) PC, PE and PS species found in the lipid extracts. (e) Bar graph showing percentage of select SM species. Bars
show mean ± SEM, n = 3 independent experiments.
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purchased from Biosolve Ltd. Phosphate buffered saline (PBS) con-
tained 5 mM KH2PO4, 15 mM K2HPO4, 150 mM NaCl, pH 7.4. Silica gel
column chromatography was performed using silica gel grade
40–63 μm (Merck). TLC analysis (during synthesis) was performed
using aluminum-backed silica gel TLC plates (60F 254, Merck), visua-
lization by UV absorption at 254 nm and/or staining with KMnO4 so-
lution.
4.1.2. General methods
NMR spectra were measured on a Bruker AV-400 MHz spectro-
meter. Chemical shifts are recorded in ppm. Tetramethylsilane (TMS)
was used as an internal standard. Coupling constants are given in Hz.
Analytical High Performance Liquid Chromatography (HPLC) analysis
was performed using a Shimadzu HPLC instrument equipped with two
LC-8A series pumps coupled to an evaporative light scattering detector
(Shimadzu ELSD-LT II detection system). Separation (Vydac 214 MS C4
column, 5 μm, 100 × 4.6 mm, flow rate: 1 ml min−1) using a linear
gradient of 10–90% B over 20 min followed by a 10 min hold at 90% B.
Initial 5 min hold at 10% B. HPLC buffers: A: H2O (0.1% TFA); B:
Acetonitrile (0.1% TFA). Flow rate: 1 ml min−1. For characterization of
NA-PEG photolysis, the ELSD drift tube temperature was set at 37 °C
and the nitrogen flow-rate at 3.5 bar. For NA-Fluo, UV detection at
214 nm was used. UV absorption spectra were measured using a Cary 3
Bio UV–Vis spectrometer, scanning from 250 nm to 550 nm at 1 nm
intervals. Scan rate: 150 nm min−1. Particle size distributions and zeta
potential measurements were obtained with DLS using a Malvern
Zetasizer Nano ZSP. To obtain an estimation of the hydrodynamic





To obtain the zeta potential (ζ), the Smoluchowski relationship was
used:
= µe
where kB is the Boltzmann constant, η and ε are the viscosity and di-
electric constant of the solvent, respectively, and D and μe represent the
measured diffusion coefficient and electrophoretic mobility of the
particle. Dh was calculated from the intensity or number weighed
particle size distribution fit of the correlation function, using the
Software provided by Malvern Instruments. The polydispersity index
(PDI) and Z-averaged Dh was provided by the cumulants fit.
Size measurements were carried out at room temperature at 1 mM
total lipid concentration in PBS. For zeta potential measurements, ve-
sicles were diluted 1:10 in 300 mM Sucrose. All reported measurements
are the average of three measurements.
MALDI-TOF mass spectra were acquired using an Applied
Biosystems Voyager System 6069 MALDI-TOF mass spectrometer. α-
Cyano-4-hydroxycinnamic acid was used as matrix in all cases. Sample
Fig. 5. Modulation of γ-secretase activity through light-triggered alteration of its local lipid environment in HEK293 (APPsw) cell membranes. (a) Hypothesis:
modulating the local physicochemical properties of HEK293 (APPsw) cell membranes due to elevated incorporation of vlcFA in PC and SM species causes a shift in
the relative amounts of different, secreted Aβ species following proteolytic processing of the APP-derived C99 substrate by γ-secretase. (b) Relative changes in Aβ38,
Aβ40 and Aβ42 production in the absence/presence of NA-PEG and absence/presence of subsequent UV irradiation. (c) Amount of Aβ42 produced relative to total Aβ
(Aβ38 + Aβ40 + Aβ42) Bars show mean ± SEM. A significant (p < 0.05, students t-test, n = 5 independent experiments) reduction in the ratio of Aβ42/Aβtotal is
only observed for cells treated with NA-PEG and subsequently irradiated.
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concentrations were ~0.3 mg ml−1.
For TEM observation, a drop of NA-PEG (500 μM, PBS) was placed
onto a nitrocellulose membrane covered TEM copper grid and dabbed
dry through the underside of the grid with a tissue. This was then
washed 3 times with ddH2O. A drop of uranyl acetate (2% w/v) in H2O
was added and the sample left to dry in the dark. Images were obtained
at an accelerating voltage of 60 kV (TEM JEOL 1010 instrument).
4.1.3. Light activation of NA-PEG
For experiments not involving cells, UV light irradiation was per-
formed using a hand-held BLAK-RAY B-100AP high intensity UV lamp
(365 nm, 100 W, 3–5 mWcm−2) encased in a cardboard box. Samples
were irradiated in quartz cuvettes at a fixed distance of 10 cm from the
UV source. For cell experiments, UV light irradiation was performed
using a high-power LED (365 nm, 15–17 mWcm−2, Roithner Laser
Technik, GmbH) or a 3UV lamp (2.8 mWcm−2, 8 W, 230 V, 50 Hz; UVP,
Upland, CA, USA) mounted at a fixed distance of 1 cm above the cells.
4.1.4. Micelle, liposome and BSA-NA preparation
Micelles of NA-PEG were prepared via lipid film hydration (PBS)
and bath sonication (Branson 2510 Ultrasonic Cleaner, 50 °C, 5 min).
POPC liposomes (10 mM) were prepared via thin film hydration and
extrusion at room temperature (Mini-extruder, Avanti Polar Lipids,
Alabaster, US). For extrusion, hydrated lipids were passed 11 times
through 2 × 400 nm (pore size) polycarbonate membranes
(Nucleopore Track-Etch membranes, Whatman), followed by 11 times
through 2 × 100 nm polycarbonate to yield large unilamellar vesicles
with a diameter of 80–90 nm. POPC liposomes were used immediately
after preparation.
BSA-NA complexes were prepared by dropwise addition of a
10 mg ml−1 solution of NA in ethanol into a sterile 0.5 mM solution of
Fatty Acid Free BSA in PBS, pH 7.4. The solution was incubated at 37 °C
for 1 h and stored at −20 °C prior to use.
4.1.5. Cell culture
Cells (HeLa (ATCC® CCL2™); HEK293 (APPsw) [22] were cultivated
in Dulbecco's Modified Eagle's Medium (DMEM), supplemented with
2% L-glutamine, 1% penicillin, 1% streptomycin and either 10% fetal
calf serum (FCS) and 200 μg ml−1 G418 (HEK293 APPsw) or iron
supplemented bovine serum (HeLa). Cells were cultured in an atmo-
sphere of 5% CO2 at 37 °C. Cell culture media were refreshed every two
days and cells passaged at 70% confluence by treatment with trypsin-
EDTA (0.05% trypsin).
4.2. Synthesis of NA-PEG and NA-Fluo
4.2.1. Methoxy-PEG2000-4-(2-methoxy-5-nitro-4-(1-(tetracos-15-
enoyloxy)ethyl)phenoxy)butanoate (NA-PEG)
To a stirred solution of o-Nb-PEG (370 mg, 0.16 mmol) in CH2Cl2
(5 ml) was added 4-dimethylaminopyridine (DMAP, 12.2 mg, 0.1 mmol),
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI, 57.5 mg,
0.30 mmol), N,N-diisopropylethylamine (DIPEA, 78.3 ml, 0.45 mmol)
and nervonic acid (92 mg, 0.25 mmol). After overnight stirring, under
N2, the reaction mixture was diluted in EtOAc (50 ml) and washed with
sat. NaHCO3 (3 × 50 ml) and brine (50 ml). The organic fractions were
combined, dried (Na2SO4) and solvent removed under vacuum. Column
chromatography (Gradient: CH2Cl2 to 10% MeOH in CH2Cl2) afforded
NA-PEG as a light yellow, waxy solid (208 mg, 0.08 mmol, 50%).
Rf: 0.38 (CH2Cl2:MeOH; 10:1)
1H NMR (CDCl3, 400 MHz): 7.60 (s, 1H), 7.02 (s, 1H), 6.49 (q,
J= 8 Hz, 1H), 5.37 (t, J= 4 Hz, 1H), 4.28 (m, 2H), 4.13 (t, J= 4 Hz,
2H), 4.02 (s, 3H), 3.45–3.95 (m, 174H), 3.41 (s, 3H), 2.60 (t, J= 4 Hz,
2H), 2.35 (m, 2H), 2.23 (m, 2H), 2.03 (m, 4H), 1.63 (d, J= 8 Hz, 1H),
1.28 (m, 32H), 0.9 (t, J = 6 Hz, 3H).
4.2.2. Synthesis of fluorescein-labeled nervonic acid, NA-Fluo
To a stirred solution of nervonic acid (20 mg, 0.05 mmol) in CH2Cl2
(2 ml) was added O-(1H-6-chlorobenzotriazole-1-yl)-1,1,3,3-tetra-
methyluronium hexafluorophosphate (HCTU, 80 mg, 0.2 mmol), DIPEA
(70 ml, 0.4 mmol) and fluoresceinamine (70 mg, 0.2 mmol). After
stirring for 5 h, the reaction solution was evaporated under vacuum.
The residue was redissolved in CH2Cl2 (10 ml) and washed with sat.
NaHCO3 (3 × 20 ml) and brine (20 ml). Column chromatography
(Gradient: CH2Cl2 to 10% MeOH in CH2Cl2), afforded fluorescein-la-
beled nervonic acid as a yellow solid (15 mg, 0.02 mmol, 45%).
Compound purity (judged to be>90%) was confirmed by analytical
HPLC (RT 29.1 min, Fig. S5).
Rf: 0.27 (CH2Cl2:MeOH; 10:1).
ESI-MS [M + H]+: found: 696.20, C44H58NO6 expected: 696.42.
4.3. Critical micelle concentration (CMC) determination
The CMC was determined by static light scattering (Malvern
Zetasizer Nano ZS) through serial dilution of micelles of NA-PEG (from
20 to 7.8 × 10−2 μM) in PBS. Measurements were carried out in tri-
plicate at 25 °C. The intensity of scattered light was plotted as a func-
tion of the concentration of NA-PEG. The CMC was determined as the
intersection of the two plots representing micelles (above the CMC) and
free molecules (below the CMC).
4.4. Interaction between micelles of NA-PEG and POPC liposomes
To four separate solutions of preformed POPC liposomes (10 μl,
10 mM in PBS) were added, either a) 90 μl PBS – to give a 1 mM of
unmodified POPC liposomes, b) 10 μl of micelles of NA-PEG (1 mM)
followed by 80 μl of PBS – to give POPC liposomes modified with NA-
PEG (1:10 mol ratio; POPC:NA-PEG) (2 separate samples), or c) 90 μl of
PBS followed by 1 μl of nervonic acid (10 mM) in EtOH. The solutions
were pipette mixed and left for 15 min at room temperature. b) was
subsequently irradiated (365 nm, 3–5 mW cm−2) for 20 min. DLS and
zeta potential measurements of all 4 samples were performed im-
mediately.
4.5. Fluorescence imaging of NA delivery of NA-PEG and NA-Fluo to cells
For fluorescence imaging HeLa cells were seeded (1 × 105 cells
cm−2) in 48-well plates (500 μl, Greiner bio-one, Cellstar®) and
Scheme S1. Methoxy-PEG2000-4-(4-(1-hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoate (o-Nb-PEG) was synthesized as previously reported [26].
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cultured for a further 24 h. Prior to testing, culture medium was care-
fully removed and the cells washed once with PBS. Micelles of NA-PEG
containing 1% of NA-Fluo were prepared by film hydration with PBS
and sonication, as for non-fluorescent micelles of NA-PEG.
Fluorescently labeled micelles (500 μM total, 5 μM NA-Fluo, 500 μl)
were added to HeLa cells and incubated for 20 min. The micelle solu-
tion was subsequently removed and cells washed with PBS (3×) and re-
suspended in DMEM+FCS. Cells were imaged immediately under the
fluorescent microscope using an Olympus IX81 fluorescence microscope
equipped with a filter cube (Ex. 470/40; Em. 525/50).
4.6. MTS assay
HEK293 (APPsw) cells were plated at a density of 6 × 105 cells
cm−2 in a 96 well plate and grown for 16 h. Micelles of NA-PEG
(100 μM) or PBS vehicle were added for 30 mins, and subsequently the
cells were irradiated (varying times, 365 nm, 2.8 mW cm−2). After 1 h
or 72 h incubation, MTS cell proliferation reagent (20 μl CellTiter 96®
AQueous One Solution Reagent, Promega) was added and the cells were
incubated for a further 2 h or 45 mins (72 h incubation). After this
incubation time, absorbance was measured at 490 nm according to the
supplier guidelines.
4.7. Lipid analysis of cell lysates by TLC
For analysis of cellular lipids, HEK293 (APPsw) cells were seeded
(8.6 × 105 cells cm−2) in 12 well plates and cultured for a further 24 h
prior to the addition of NA-PEG at a final concentration of 100 μM.
After 30 mins, cells were irradiated (10 min, 365 nm, 2.8 mWcm−2)
and incubated for a further 72 h. The medium was then changed for 5 h.
Cells were then scraped and washed twice in ice-cold PBS by cen-
trifugation at 2500g for 10 min at 4 °C. 25–50% of the cell pellet was re-
suspended in CHCl3:MeOH (1:2). To extract cellular lipids, pellets were
briefly (bath) sonicated before centrifugation at 17000g for 10 min at
4 °C. The supernatant containing cellular lipids was resolved by TLC
using a mobile phase of CHCl3:MeOH:H2O (65:25:4). In this solvent
system, the phospholipids phosphatidylcholine, phosphatidylinositol
and phosphatidylserine co-migrate as one spot (PL). Synthetic 24:1 PC,
22:1 PC and POPC were used as standards. TLC analysis was performed
using Silica HPTLC plates (Millipore Cat no: 1.05644.001), developed
by spraying with 10% CuSO4 (w/v) in 8% phosphoric acid (v/v) and
charring at 95 °C overnight on a hot plate. Sarstedt polypropylene re-
action tubes (Product no. 72.690.001) were used for lipid extraction.
4.8. Lipidomics
Lipidomic analysis of HEK293 (APPsw) lipid extracts was performed
using a LC-MS/MS based lipid profiling method using a Shimadzu
Nexera X2 system consisting of LC-30 pumps, a SIL30AC autosampler
and a CTO-20AC column oven kept at 50 °C (Shimadzu, 's
Hertogenbosch, The Netherlands). A gradient of water/acetonitrile
80:20 v/v (eluent A) and water/acetonitrile/2-propanol 1:90:90 v/v
(eluent B) was used. Both eluents contained 5 mM ammonium formate
and 0.05% formic acid. The applied gradient, with a column flow of
300 μl min−1, was as follows: 0 min 40% B, 10 min 100% B, 12 min
100% B. A Phenomenex Kinetex C18, 2.7 μm particles, 50 × 2.1 mm
(Phenomenex, Utrecht, The Netherlands) was used as column. Lipid
extracts were dissolved in 100 μl 2-propanol followed by 5 min of ul-
trasonification. Subsequently, samples were diluted with 100 μl water
and 10 μl was injected into the LC-MS system. The MS was a Sciex
TripleTOF 6600 (AB Sciex Netherlands B.V., Nieuwerkerk aan den
Ijssel, The Netherlands) operated in positive (ESI+) and negative
(ESI−) ESI mode, with the following conditions: Ion Source Gas 1, 2
and Curtain gas 30 psi, temperature 350 °C, acquisition range m/z
100–1200, IonSpray Voltage 5500 V (ESI+) and −4500 V (ESI-), de-
clustering potential 80 V (ESI+) and −80 V (ESI−). An information
dependent acquisition (IDA) method was used to identify lipids, with
the following conditions for MS analysis: collision energy± 10, ac-
quisition time 250 ms and for MS/MS analysis: collision energy± 45,
collision energy spread 25, ion release delay 30, ion release width 14,
acquisition time 40 ms. The IDA switching criteria where set as: for ions
greater than m/z 300, which exceed 200 cps, exclude former target for
2 s, exclude isotopes within 1.5 Da, max. candidate ions 20.
Before data analysis, raw MS data files where converted with the
Reifycs Abf Converter (v1.1) to the Abf file. MS-DIAL (v2.74), with the
FiehnO (VS27) database, was used to align the data and identify the
different lipids [27]. PC and PE lipids were manually curated to confirm
their identity. Due to overlap of triglyceride (TG) species, MS-DIAL
could not sufficiently identify lipid species, in turn a modified identi-
fication approach was applied. Initially, MS-DIAL was used to get the
total number of carbons and double bonds of a TG. This information
together with the MS/MS spectrum was used to search the glycerolipid
MS/MS predicted database on LipidMaps [28]. TG's with all their
neutral loss of lipid species fragments matched where assigned as cor-
rectly identified. Raw lipidomics data is included as a separate excel
file.
4.9. Analysis of Aβ generation
HEK293 cells overexpressing APPsw were cultured and treated with
NA-PEG as outlined above (Section 4.7). Conditioned medium (5 h) was
centrifuged at 2500 ×g for 10 min to clear cellular debris, prior to
analysis by triplex sandwich immunoassay specific for Aβ38, Aβ40, and
Aβ42 species (Meso Scale Discovery).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbamem.2020.183200.
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